Pfizer, J&J scrap Alzheimer's studies as drug fails

NEW YORK (Reuters) - Pfizer Inc and Johnson & Johnson scrapped further studies of one of the most anticipated experimental drugs for Alzheimer's disease after it failed to help patients with the memory-robbing condition in a second high-profile clinical trial.

average price for a wedding ring average price of computers increase in house prices